Clinical pattern of checkpoint inhibitor-induced liver injury in a multicentre cohort

BACKGROUND & AIMS: Immune checkpoint inhibitors (ICIs) have changed the landscape of cancer therapy. Liver toxicity occurs in up to 25% of patients treated with ICIs. The aim of our study was to describe the different clinical patterns of ICI-induced hepatitis and to assess their outcome. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Hountondji, Lina, Ferreira De Matos, Christophe, Lebossé, Fanny, Quantin, Xavier, Lesage, Candice, Palassin, Pascale, Rivet, Valérian, Faure, Stéphanie, Pageaux, Georges-Philippe, Assenat, Éric, Alric, Laurent, Zahhaf, Amel, Larrey, Dominique, Witkowski Durand Viel, Philine, Riviere, Benjamin, Janick, Selves, Dalle, Stéphane, Maria, Alexandre Thibault Jacques, Comont, Thibaut, Meunier, Lucy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149360/
https://www.ncbi.nlm.nih.gov/pubmed/37138674
http://dx.doi.org/10.1016/j.jhepr.2023.100719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149360/
https://www.ncbi.nlm.nih.gov/pubmed/37138674
http://dx.doi.org/10.1016/j.jhepr.2023.100719

Ejemplares similares